{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T05:36:57Z","timestamp":1794461817362,"version":"4.9.1"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,6,5]],"date-time":"2020-06-05T00:00:00Z","timestamp":1591315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,6,5]],"date-time":"2020-06-05T00:00:00Z","timestamp":1591315200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2021,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Subtotal gastrectomy with Billroth II reconstruction (SGB2) results in increased gastric pH and diminished gastric barrier. Increased gastric pH following PPI therapy has an impact on the gut microbiome, intestinal inflammation, and possibly patient health. If similar changes are present after SGB2, these can be relevant for patient health and long-term outcomes after surgery. The aim of the study is to investigate whether SGB2 is associated with specific changes in gut microbiome composition and intestinal inflammation.<\/jats:p><\/jats:sec><jats:sec><jats:title>Patients and Methods<\/jats:title><jats:p>This cross-sectional proof-of-concept study includes patients after SGB2 (<jats:italic>n<\/jats:italic>\u2009=\u200914) for early gastric cancer and their nongastrectomized in-house relatives as controls (<jats:italic>n<\/jats:italic>\u2009=\u20098). Fecal microbiome composition, intestinal inflammation (fecal calprotectin), gut permeability (DAO, LBP, sCD14), systemic inflammation (CRP) markers, and gastrointestinal symptoms are investigated. This study is registered at ClinicalTrials.gov (NCT03418428).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Microbiome oralization following SGB2 was defined by an increase in<jats:italic>Escherichia<\/jats:italic>\u2013<jats:italic>Shigella<\/jats:italic>,<jats:italic>Enterococcus<\/jats:italic>,<jats:italic>Streptococcus<\/jats:italic>, and other typical oral cavity bacteria (<jats:italic>Veillonella<\/jats:italic>,<jats:italic>Oribacterium<\/jats:italic>, and<jats:italic>Mogibacterium<\/jats:italic>) abundance. The fecal calprotectin was increased in the SGB2 group [100.9 (52.1; 292) vs. 25.8 (17; 66.5);<jats:italic>p<\/jats:italic>\u2009=\u20090.014], and calprotectin levels positively correlated with the abundance of<jats:italic>Streptococcus<\/jats:italic>(<jats:italic>r<\/jats:italic><jats:sub>s<\/jats:sub>\u2009=\u20090.639;<jats:italic>p<\/jats:italic><jats:sub>adj<\/jats:sub>\u2009=\u20090.023). Gastrointestinal symptoms in SGB2 patients were associated with distinct taxonomic changes of the gut microbiome.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>SGB2 is associated with oralization of the gut microbiome; intestinal inflammation and microbiome changes were associated with gastrointestinal symptoms. These novel findings may open gut microbiome as a new target for therapy to improve quality of life and general patient health in long-term survivors after SGB2.<\/jats:p><\/jats:sec>","DOI":"10.1245\/s10434-020-08678-1","type":"journal-article","created":{"date-parts":[[2020,6,5]],"date-time":"2020-06-05T21:02:57Z","timestamp":1591390977000},"page":"1198-1208","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Distal Gastrectomy with Billroth II Reconstruction is Associated with Oralization of Gut Microbiome and Intestinal Inflammation: A Proof-of-Concept Study"],"prefix":"10.1245","volume":"28","clinical-trial-number":[{"clinical-trial-number":"nct03418428","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Angela","family":"Horvath","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1848-2960","authenticated-orcid":false,"given":"Augustinas","family":"Bausys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasa","family":"Sabaliauskaite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenijus","family":"Stratilatovas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonata","family":"Jarmalaite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burkhard","family":"Schuetz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Stiegler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rimantas","family":"Bausys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Stadlbauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kestutis","family":"Strupas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,5]]},"reference":[{"issue":"24","key":"8678_CR1","doi-asserted-by":"publisher","first-page":"2567","DOI":"10.3748\/wjg.v24.i24.2567","volume":"24","author":"J-P Gao","year":"2018","unstructured":"Gao J-P, Xu W, Liu W-T, Yan M, Zhu Z-G. Tumor heterogeneity of gastric cancer: from the perspective of tumor-initiating cell. World J Gastroenterol. 2018;24(24):2567\u201381.","journal-title":"World J Gastroenterol."},{"issue":"1","key":"8678_CR2","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.ejso.2015.10.016","volume":"42","author":"L Marano","year":"2016","unstructured":"Marano L, Polom K, Patriti A, Roviello G, Falco G, Stracqualursi A, et al. Surgical management of advanced gastric cancer: an evolving issue. Eur J Surg Oncol. 2016;42(1):18\u201327.","journal-title":"Eur J Surg Oncol"},{"issue":"3","key":"8678_CR3","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1007\/s10120-015-0547-3","volume":"19","author":"TB Tran","year":"2016","unstructured":"Tran TB, Worhunsky DJ, Squires MH, Jin LX, Spolverato G, Votanopoulos KI, et al. To Roux or not to Roux: a comparison between Roux-en-Y and Billroth II reconstruction following partial gastrectomy for gastric cancer. Gastric Cancer. 2016;19(3):994\u20131001.","journal-title":"Gastric Cancer."},{"issue":"22","key":"8678_CR4","doi-asserted-by":"publisher","first-page":"6981","DOI":"10.3748\/wjg.v20.i22.6981","volume":"20","author":"L Huang","year":"2014","unstructured":"Huang L, Xu A-M, Li T-J, Han W-X, Xu J. Should peri-gastrectomy gastric acidity be our focus among gastric cancer patients? World J Gastroenterol. 2014;20(22):6981.","journal-title":"World J Gastroenterol."},{"issue":"6","key":"8678_CR5","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/S0016-5085(19)33983-6","volume":"55","author":"K Jepson","year":"1968","unstructured":"Jepson K, Johnston D. Effect of vagotomy on human gastric acid secretion stimulated by gastrin pentapeptide and by histalog. Gastroenterology. 1968;55(6):665\u20139.","journal-title":"Gastroenterology."},{"issue":"9","key":"8678_CR6","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1007\/BF01537576","volume":"35","author":"PN Rieu","year":"1990","unstructured":"Rieu PN, Jansen JB, Hopman WP, Joosten HJ, Lamers CB. Effect of partial gastrectomy with Billroth II or Roux-en-Y anastomosis on postprandial and cholecystokinin-stimulated gallbladder contraction and secretion of cholecystokinin and pancreatic polypeptide. Dig Dis Sci. 1990;35(9):1066\u201372.","journal-title":"Dig Dis Sci."},{"key":"8678_CR7","doi-asserted-by":"crossref","unstructured":"Tseng C-H, Lin J-T, Ho HJ, Lai Z-L, Wang C-B, Tang S-L, et al. Gastric microbiota and predicted gene functions are altered after subtotal gastrectomy in patients with gastric cancer. Sci Rep. 2016 Feb 10 [cited 2019 Apr 18];6. https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC4748256\/.","DOI":"10.1038\/srep20701"},{"issue":"5","key":"8678_CR8","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1136\/gutjnl-2015-310376","volume":"65","author":"F Imhann","year":"2016","unstructured":"Imhann F, Bonder MJ, Vich Vila A, Fu J, Mujagic Z, Vork L, et al. Proton pump inhibitors affect the gut microbiome. Gut. 2016;65(5):740\u20138.","journal-title":"Gut."},{"issue":"5","key":"8678_CR9","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1136\/gutjnl-2015-310861","volume":"65","author":"MA Jackson","year":"2016","unstructured":"Jackson MA, Goodrich JK, Maxan M-E, Freedberg DE, Abrams JA, Poole AC, et al. Proton pump inhibitors alter the composition of the gut microbiota. Gut. 2016;65(5):749\u201356.","journal-title":"Gut."},{"key":"8678_CR10","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/2049-2618-2-42","volume":"2","author":"CT Seto","year":"2014","unstructured":"Seto CT, Jeraldo P, Orenstein R, Chia N, DiBaise JK. Prolonged use of a proton pump inhibitor reduces microbial diversity: implications for Clostridium difficile susceptibility. Microbiome. 2014;2:42.","journal-title":"Microbiome."},{"issue":"6","key":"8678_CR11","doi-asserted-by":"publisher","first-page":"e89","DOI":"10.1038\/ctg.2015.20","volume":"6","author":"A Tsuda","year":"2015","unstructured":"Tsuda A, Suda W, Morita H, Takanashi K, Takagi A, Koga Y, et al. Influence of proton-pump inhibitors on the luminal microbiota in the gastrointestinal tract. Clin Transl Gastroenterol. 2015;6(6):e89.","journal-title":"Clin Transl Gastroenterol."},{"issue":"10","key":"8678_CR12","doi-asserted-by":"publisher","first-page":"G951","DOI":"10.1152\/ajpgi.00268.2014","volume":"307","author":"JS Bajaj","year":"2014","unstructured":"Bajaj JS, Cox IJ, Betrapally NS, Heuman DM, Schubert ML, Ratneswaran M, et al. Systems biology analysis of omeprazole therapy in cirrhosis demonstrates significant shifts in gut microbiota composition and function. Am J Physiol Gastrointest Liver Physiol. 2014;307(10):G951\u20137.","journal-title":"Am J Physiol Gastrointest Liver Physiol."},{"issue":"9","key":"8678_CR13","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1111\/apt.13568","volume":"43","author":"AG Clooney","year":"2016","unstructured":"Clooney AG, Bernstein CN, Leslie WD, Vagianos K, Sargent M, Laserna-Mendieta EJ, et al. A comparison of the gut microbiome between long-term users and non-users of proton pump inhibitors. Aliment Pharmacol Ther. 2016;43(9):974\u201384.","journal-title":"Aliment Pharmacol Ther."},{"key":"8678_CR14","doi-asserted-by":"crossref","unstructured":"Horvath A, Rainer F, Bashir M, Leber B, Schmerboeck B, Klymiuk I, et al. Biomarkers for oralization during long-term proton pump inhibitor therapy predict survival in cirrhosis. Sci Rep. 2019 Aug 19 [cited 2019 Sep 5];9. https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC6700098\/.","DOI":"10.1038\/s41598-019-48352-5"},{"issue":"1","key":"8678_CR15","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1038\/s41467-017-00796-x","volume":"8","author":"C Llorente","year":"2017","unstructured":"Llorente C, Jepsen P, Inamine T, Wang L, Bluemel S, Wang HJ, et al. Gastric acid suppression promotes alcoholic liver disease by inducing overgrowth of intestinal Enterococcus. Nat Commun. 2017;8(1):837.","journal-title":"Nat Commun."},{"issue":"4","key":"8678_CR16","first-page":"281","volume":"25","author":"N Uedo","year":"2012","unstructured":"Uedo N, Takeuchi Y, Ishihara R. Endoscopic management of early gastric cancer: endoscopic mucosal resection or endoscopic submucosal dissection: data from a Japanese high-volume center and literature review. Ann Gastroenterol. 2012;25(4):281\u201390.","journal-title":"Ann Gastroenterol."},{"issue":"1","key":"8678_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10120-016-0622-4","volume":"20","author":"Japanese Gastric Cancer Association","year":"2017","unstructured":"Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2014 (ver. 4). Gastric Cancer. 2017;20(1):1\u201319. https:\/\/doi.org\/10.1007\/s10120-016-0622-4.","journal-title":"Gastric Cancer."},{"issue":"1","key":"8678_CR18","doi-asserted-by":"publisher","first-page":"15601","DOI":"10.1038\/s41598-017-15650-9","volume":"7","author":"V Stadlbauer","year":"2017","unstructured":"Stadlbauer V, Horvath A, Ribitsch W, Schmerb\u00f6ck B, Schilcher G, Lemesch S, et al. Structural and functional differences in gut microbiome composition in patients undergoing haemodialysis or peritoneal dialysis. Sci Rep. 2017;7(1):15601.","journal-title":"Sci Rep."},{"issue":"5","key":"8678_CR19","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/nmeth.f.303","volume":"7","author":"JG Caporaso","year":"2010","unstructured":"Caporaso JG, Kuczynski J, Stombaugh J, Bittinger K, Bushman FD, Costello EK, et al. QIIME allows analysis of high-throughput community sequencing data. Nat Methods. 2010;7(5):335\u20136.","journal-title":"Nat Methods."},{"issue":"7","key":"8678_CR20","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/nmeth.3869","volume":"13","author":"BJ Callahan","year":"2016","unstructured":"Callahan BJ, McMurdie PJ, Rosen MJ, Han AW, Johnson AJA, Holmes SP. DADA2: high-resolution sample inference from Illumina amplicon data. Nat Methods. 2016;13(7):581\u20133.","journal-title":"Nat Methods."},{"issue":"4","key":"8678_CR21","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.cll.2014.08.008","volume":"34","author":"DE Freedberg","year":"2014","unstructured":"Freedberg DE, Lebwohl B, Abrams JA. The impact of proton pump inhibitors on the human gastrointestinal microbiome. Clin Lab Med. 2014;34(4):771\u201385.","journal-title":"Clin Lab Med."},{"issue":"2","key":"8678_CR22","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1111\/j.1742-7843.2005.pto960202.x","volume":"96","author":"TC Martinsen","year":"2005","unstructured":"Martinsen TC, Bergh K, Waldum HL. Gastric juice: a barrier against infectious diseases. Basic Clin Pharmacol Toxicol. 2005;96(2):94\u2013102.","journal-title":"Basic Clin Pharmacol Toxicol."},{"issue":"4","key":"8678_CR23","doi-asserted-by":"publisher","first-page":"461","DOI":"10.3109\/00365528609015163","volume":"21","author":"M Carboni","year":"1986","unstructured":"Carboni M, Guadagni S, Pistoia MA, Amicucci G, Tuscano D, Negro P, et al. The microflora of the gastric juice after Billroth I and Billroth II partial gastrectomy. Scand J Gastroenterol. 1986;21(4):461\u201370.","journal-title":"Scand J Gastroenterol."},{"issue":"5","key":"8678_CR24","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1177\/2040622313496126","volume":"4","author":"AH Sachdev","year":"2013","unstructured":"Sachdev AH, Pimentel M. Gastrointestinal bacterial overgrowth: pathogenesis and clinical significance. Ther Adv Chronic Dis. 2013;4(5):223\u201331.","journal-title":"Ther Adv Chronic Dis."},{"issue":"5","key":"8678_CR25","doi-asserted-by":"publisher","first-page":"e191","DOI":"10.1111\/j.1365-2982.2011.01686.x","volume":"23","author":"CN Paik","year":"2011","unstructured":"Paik CN, Choi M-G, Lim CH, Park JM, Chung WC, Lee K-M, et al. The role of small intestinal bacterial overgrowth in postgastrectomy patients. Neurogastroenterol Motil. 2011;23(5):e191\u20136.","journal-title":"Neurogastroenterol Motil Off J Eur Gastrointest Motil Soc."},{"issue":"5","key":"8678_CR26","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1016\/j.jpeds.2015.01.004","volume":"166","author":"A Sieczkowska","year":"2015","unstructured":"Sieczkowska A, Landowski P, Zagozdzon P, Kaminska B, Lifschitz C. Small bowel bacterial overgrowth associated with persistence of abdominal symptoms in children treated with a proton pump inhibitor. J Pediatr. 2015;166(5):1310\u201312.e1.","journal-title":"J Pediatr."},{"issue":"6","key":"8678_CR27","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1128\/JB.176.6.1729-1737.1994","volume":"176","author":"P Small","year":"1994","unstructured":"Small P, Blankenhorn D, Welty D, Zinser E, Slonczewski JL. Acid and base resistance in Escherichia coli and Shigella flexneri: role of rpoS and growth pH. J Bacteriol. 1994;176(6):1729\u201337.","journal-title":"J Bacteriol."},{"issue":"3","key":"8678_CR28","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.4143\/crt.2015.398","volume":"48","author":"W Yu","year":"2016","unstructured":"Yu W, Park KB, Chung HY, Kwon OK, Lee SS. Chronological changes of quality of life in long-term survivors after gastrectomy for gastric cancer. Cancer Res Treat. 2016;48(3):1030\u20136.","journal-title":"Cancer Res Treat."},{"issue":"7","key":"8678_CR29","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.ijsu.2014.05.067","volume":"12","author":"SS Lee","year":"2014","unstructured":"Lee SS, Chung HY, Kwon OK, Yu W. Quality of life in cancer survivors 5\u00a0years or more after total gastrectomy: a case-control study. Int J Surg Lond Engl. 2014;12(7):700\u20135.","journal-title":"Int J Surg Lond Engl."},{"issue":"3","key":"8678_CR30","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1007\/s10120-017-0771-0","volume":"21","author":"HJF Brenkman","year":"2018","unstructured":"Brenkman HJF, Tegels JJW, Ruurda JP, Luyer MDP, Kouwenhoven EA, Draaisma WA, et al. Factors influencing health-related quality of life after gastrectomy for cancer. Gastric Cancer. 2018;21(3):524\u201332.","journal-title":"Gastric Cancer."},{"issue":"648","key":"8678_CR31","doi-asserted-by":"publisher","first-page":"350","DOI":"10.3399\/bjgp16X685813","volume":"66","author":"M Cohen","year":"2016","unstructured":"Cohen M. Proton pump inhibitors may cause elevation in faecal calprotectin levels. Br J Gen Pract. 2016;66(648):350.","journal-title":"Br J Gen Pract."},{"issue":"5","key":"8678_CR32","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1097\/00042737-200305000-00021","volume":"15","author":"A Poullis","year":"2003","unstructured":"Poullis A, Foster R, Mendall MA, Shreeve D, Wiener K. Proton pump inhibitors are associated with elevation of faecal calprotectin and may affect specificity. Eur J Gastroenterol Hepatol. 2003;15(5):573\u20134; author reply 574.","journal-title":"Eur J Gastroenterol Hepatol."},{"key":"8678_CR33","doi-asserted-by":"crossref","unstructured":"Anbazhagan AN, Priyamvada S, Alrefai WA, Dudeja PK. Pathophysiology of IBD associated diarrhea. Tissue Barriers. 2018 May 8 [cited 2019 Sep 14];6(2). https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC6179131\/.","DOI":"10.1080\/21688370.2018.1463897"},{"issue":"6","key":"8678_CR34","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1097\/SLA.0b013e31828c4a19","volume":"257","author":"PJ Karanicolas","year":"2013","unstructured":"Karanicolas PJ, Graham D, G\u00f6nen M, Strong VE, Brennan MF, Coit DG. Quality of life after gastrectomy for adenocarcinoma: a prospective cohort study. Ann Surg. 2013;257(6):1039\u201346.","journal-title":"Ann Surg."},{"issue":"6","key":"8678_CR35","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1097\/SLA.0b013e31827661c9","volume":"256","author":"AR Kim","year":"2012","unstructured":"Kim AR, Cho J, Hsu Y-J, Choi MG, Noh JH, Sohn TS, et al. Changes of quality of life in gastric cancer patients after curative resection: a longitudinal cohort study in Korea. Ann Surg. 2012;256(6):1008\u201313.","journal-title":"Ann Surg."},{"issue":"4","key":"8678_CR36","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1007\/s10120-011-0129-y","volume":"15","author":"T Aoki","year":"2012","unstructured":"Aoki T, Yamaji I, Hisamoto T, Sato M, Matsuda T. Irregular bowel movement in gastrectomized subjects: bowel habits, stool characteristics, fecal flora, and metabolites. Gastric Cancer. 2012;15(4):396\u2013404.","journal-title":"Gastric Cancer."},{"key":"8678_CR37","doi-asserted-by":"publisher","first-page":"2558","DOI":"10.3389\/fmicb.2018.02558","volume":"9","author":"EH Crost","year":"2018","unstructured":"Crost EH, Le Gall G, Laverde-Gomez JA, Mukhopadhya I, Flint HJ, Juge N. Mechanistic insights into the cross-feeding of Ruminococcus gnavus and Ruminococcus bromii on host and dietary carbohydrates. Front Microbiol. 2018;9:2558.","journal-title":"Front Microbiol."},{"issue":"Pt 5","key":"8678_CR38","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1099\/jmm.0.47615-0","volume":"58","author":"A Engelbrektson","year":"2009","unstructured":"Engelbrektson A, Korzenik JR, Pittler A, Sanders ME, Klaenhammer TR, Leyer G, et al. Probiotics to minimize the disruption of faecal microbiota in healthy subjects undergoing antibiotic therapy. J Med Microbiol. 2009;58(Pt 5):663\u201370.","journal-title":"J Med Microbiol."},{"issue":"12","key":"8678_CR39","doi-asserted-by":"publisher","first-page":"e923","DOI":"10.1002\/mbo3.923","volume":"8","author":"Q Yang","year":"2019","unstructured":"Yang Q, Huang X, Wang P, Yan Z, Sun W, Zhao S, et al. Longitudinal development of the gut microbiota in healthy and diarrheic piglets induced by age-related dietary changes. MicrobiologyOpen. 2019;8(12):e923. https:\/\/doi.org\/10.1002\/mbo3.923.","journal-title":"MicrobiologyOpen."},{"issue":"3","key":"8678_CR40","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s12088-017-0652-6","volume":"57","author":"Z Qiu","year":"2017","unstructured":"Qiu Z, Yang H, Rong L, Ding W, Chen J, Zhong L. Targeted metagenome based analyses show gut microbial diversity of inflammatory bowel disease patients. Indian J Microbiol. 2017;57(3):307\u201315.","journal-title":"Indian J Microbiol."},{"issue":"6","key":"8678_CR41","doi-asserted-by":"publisher","first-page":"e39743","DOI":"10.1371\/journal.pone.0039743","volume":"7","author":"W Chen","year":"2012","unstructured":"Chen W, Liu F, Ling Z, Tong X, Xiang C. Human intestinal lumen and mucosa-associated microbiota in patients with colorectal cancer. PLoS ONE. 2012;7(6):e39743.","journal-title":"PloS One."},{"issue":"22","key":"8678_CR42","doi-asserted-by":"publisher","first-page":"7767","DOI":"10.1128\/AEM.02089-15","volume":"81","author":"A Rivi\u00e8re","year":"2015","unstructured":"Rivi\u00e8re A, Gagnon M, Weckx S, Roy D, De Vuyst L. Mutual cross-feeding interactions between Bifidobacterium longum subsp. longum NCC2705 and Eubacterium rectale ATCC 33656 explain the Bifidogenic and Butyrogenic effects of Arabinoxylan Oligosaccharides. Appl Environ Microbiol. 2015;81(22):7767\u201381.","journal-title":"Appl Environ Microbiol."},{"key":"8678_CR43","doi-asserted-by":"publisher","first-page":"84","DOI":"10.3389\/fcimb.2015.00084","volume":"5","author":"NO Kaakoush","year":"2015","unstructured":"Kaakoush NO. Insights into the role of erysipelotrichaceae in the human host. Front Cell Infect Microbiol. 2015;5:84.","journal-title":"Front Cell Infect Microbiol."},{"issue":"7","key":"8678_CR44","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1046\/j.1365-2036.2003.01543.x","volume":"17","author":"HJ Kim","year":"2003","unstructured":"Kim HJ, Camilleri M, McKinzie S, Lempke MB, Burton DD, Thomforde GM, et al. A randomized controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome. Aliment Pharmacol Ther. 2003;17(7):895\u2013904.","journal-title":"Aliment Pharmacol Ther."},{"issue":"1","key":"8678_CR45","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1097\/MPG.0b013e3181ca4d95","volume":"51","author":"S Guandalini","year":"2010","unstructured":"Guandalini S, Magazz\u00f9 G, Chiaro A, La Balestra V, Di Nardo G, Gopalan S, et al. VSL#3 improves symptoms in children with irritable bowel syndrome: a multicenter, randomized, placebo-controlled, double-blind, crossover study. J Pediatr Gastroenterol Nutr. 2010;51(1):24\u201330.","journal-title":"J Pediatr Gastroenterol Nutr."},{"issue":"1\u20132","key":"8678_CR46","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1089\/jmf.2008.0328","volume":"14","author":"E Nova","year":"2011","unstructured":"Nova E, Viadel B, W\u00e4rnberg J, Carreres JE, Marcos A. Beneficial effects of a synbiotic supplement on self-perceived gastrointestinal well-being and immunoinflammatory status of healthy adults. J Med Food. 2011;14(1\u20132):79\u201385.","journal-title":"J Med Food."},{"issue":"7","key":"8678_CR47","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1016\/j.soard.2017.03.014","volume":"13","author":"BK Canales","year":"2017","unstructured":"Canales BK, Hatch M. Oxalobacter formigenes colonization normalizes oxalate excretion in a gastric bypass model of hyperoxaluria. Surg Obes Relat Dis. 2017;13(7):1152\u20137.","journal-title":"Surg Obes Relat Dis."},{"issue":"4","key":"8678_CR48","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s00240-017-0998-6","volume":"46","author":"D Milliner","year":"2018","unstructured":"Milliner D, Hoppe B, Groothoff J. A randomised Phase II\/III study to evaluate the efficacy and safety of orally administered Oxalobacter formigenes to treat primary hyperoxaluria. Urolithiasis. 2018;46(4):313\u201323.","journal-title":"Urolithiasis."},{"key":"8678_CR49","doi-asserted-by":"publisher","first-page":"e00458","DOI":"10.7554\/eLife.00458","volume":"2","author":"SJ Song","year":"2013","unstructured":"Song SJ, Lauber C, Costello EK, Lozupone CA, Humphrey G, Berg-Lyons D, et al. Cohabiting family members share microbiota with one another and with their dogs. eLife. 2013;2:e00458.","journal-title":"eLife"},{"issue":"7695","key":"8678_CR50","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1038\/nature25973","volume":"555","author":"D Rothschild","year":"2018","unstructured":"Rothschild D, Weissbrod O, Barkan E, Kurilshikov A, Korem T, Zeevi D, et al. Environment dominates over host genetics in shaping human gut microbiota. Nature. 2018;555(7695):210\u20135.","journal-title":"Nature."},{"issue":"4","key":"8678_CR51","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1111\/liv.14382","volume":"40","author":"V Stadlbauer","year":"2020","unstructured":"Stadlbauer V, Komarova I, Klymiuk I, Durdevic M, Reisinger A, Blesl A, et al. Disease severity and proton pump inhibitor use impact strongest on faecal microbiome composition in liver cirrhosis. Liver Int. 2020;40(4):866\u201377. https:\/\/doi.org\/10.1111\/liv.14382.","journal-title":"Liver Int."},{"issue":"1","key":"8678_CR52","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s40168-017-0296-0","volume":"5","author":"TW Buford","year":"2017","unstructured":"Buford TW. (Dis)Trust your gut: the gut microbiome in age-related inflammation, health, and disease. Microbiome. 2017;5(1):80.","journal-title":"Microbiome."},{"issue":"2","key":"8678_CR53","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1128\/AEM.72.2.1027-1033.2006","volume":"72","author":"S Mueller","year":"2006","unstructured":"Mueller S, Saunier K, Hanisch C, Norin E, Alm L, Midtvedt T, et al. Differences in fecal microbiota in different European study populations in relation to age, gender, and country: a cross-sectional study. Appl Environ Microbiol. 2006;72(2):1027\u201333.","journal-title":"Appl Environ Microbiol."},{"issue":"5","key":"8678_CR54","doi-asserted-by":"publisher","first-page":"e0154090","DOI":"10.1371\/journal.pone.0154090","volume":"11","author":"C Haro","year":"2016","unstructured":"Haro C, Rangel-Z\u00fa\u00f1iga OA, Alcal\u00e1-D\u00edaz JF, G\u00f3mez-Delgado F, P\u00e9rez-Mart\u00ednez P, Delgado-Lista J, et al. Intestinal microbiota is influenced by gender and body mass index. PLoS ONE. 2016;11(5):e0154090.","journal-title":"PloS One."},{"issue":"6123","key":"8678_CR55","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1126\/science.1233521","volume":"339","author":"JGM Markle","year":"2013","unstructured":"Markle JGM, Frank DN, Mortin-Toth S, Robertson CE, Feazel LM, Rolle-Kampczyk U, et al. Sex differences in the gut microbiome drive hormone-dependent regulation of autoimmunity. Science. 2013;339(6123):1084\u20138.","journal-title":"Science."},{"issue":"5","key":"8678_CR56","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1111\/apt.13302","volume":"42","author":"E Montassier","year":"2015","unstructured":"Montassier E, Gastinne T, Vangay P, Al-Ghalith GA, Bruley des Varannes S, Massart S, et al. Chemotherapy-driven dysbiosis in the intestinal microbiome. Aliment Pharmacol Ther. 2015;42(5):515\u201328.","journal-title":"Aliment Pharmacol Ther."},{"issue":"2","key":"8678_CR57","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1086\/599346","volume":"49","author":"MJ van Vliet","year":"2009","unstructured":"van Vliet MJ, Tissing WJE, Dun CAJ, Meessen NEL, Kamps WA, de Bont ESJM, et al. Chemotherapy treatment in pediatric patients with acute myeloid leukemia receiving antimicrobial prophylaxis leads to a relative increase of colonization with potentially pathogenic bacteria in the gut. Clin Infect Dis. 2009;49(2):262\u201370.","journal-title":"Clin Infect Dis."},{"issue":"1","key":"8678_CR58","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1186\/s12885-019-6473-8","volume":"19","author":"JM Deleemans","year":"2019","unstructured":"Deleemans JM, Chleilat F, Reimer RA, Henning J-W, Baydoun M, Piedalue K-A, et al. The chemo-gut study: investigating the long-term effects of chemotherapy on gut microbiota, metabolic, immune, psychological and cognitive parameters in young adult cancer survivors; study protocol. BMC Cancer. 2019;19(1):1243.","journal-title":"BMC Cancer."},{"issue":"11","key":"8678_CR59","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1038\/s41564-018-0257-9","volume":"3","author":"A Palleja","year":"2018","unstructured":"Palleja A, Mikkelsen KH, Forslund SK, Kashani A, Allin KH, Nielsen T, et al. Recovery of gut microbiota of healthy adults following antibiotic exposure. Nat Microbiol. 2018;3(11):1255\u201365.","journal-title":"Nat Microbiol."},{"key":"8678_CR60","doi-asserted-by":"crossref","unstructured":"Lin X-H, Huang K-H, Chuang W-H, Luo J-C, Lin C-C, Ting P-H, et al. The long term effect of metabolic profile and microbiota status in early gastric cancer patients after subtotal gastrectomy. PLoS ONE. 2018 [cited 2019 Apr 29];13(11). https:\/\/www-1ncbi-1nlm-1nih-1gov-10013b5s10da2.han.medunigraz.at\/pmc\/articles\/PMC6218198\/.","DOI":"10.1371\/journal.pone.0206930"},{"issue":"1","key":"8678_CR61","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/s41467-019-14177-z","volume":"11","author":"A Vich Vila","year":"2020","unstructured":"Vich Vila A, Collij V, Sanna S, Sinha T, Imhann F, Bourgonje AR, et al. Impact of commonly used drugs on the composition and metabolic function of the gut microbiota. Nat Commun. 2020;11(1):362.","journal-title":"Nat Commun."},{"key":"8678_CR62","doi-asserted-by":"publisher","unstructured":"Information Committee of Korean Gastric Cancer Association. Korean gastric cancer association nationwide survey on gastric cancer in 2014 [published correction appears in J Gastric Cancer. 2016 Dec;16(4):277]. J Gastric Cancer. 2016;16(3):131\u201340. https:\/\/doi.org\/10.5230\/jgc.2016.16.3.131.","DOI":"10.5230\/jgc.2016.16.3.131"},{"issue":"7","key":"8678_CR63","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.3748\/wjg.v19.i7.1124","volume":"19","author":"J-J Xiong","year":"2013","unstructured":"Xiong J-J, Altaf K, Javed MA, Nunes QM, Huang W, Mai G, et al. Roux-en-Y versus Billroth I reconstruction after distal gastrectomy for gastric cancer: a meta-analysis. World J Gastroenterol. 2013;19(7):1124\u201334.","journal-title":"World J Gastroenterol WJG."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-020-08678-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-020-08678-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-020-08678-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,26]],"date-time":"2022-10-26T21:33:24Z","timestamp":1666820004000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-020-08678-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,5]]},"references-count":63,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["8678"],"URL":"https:\/\/doi.org\/10.1245\/s10434-020-08678-1","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,5]]},"assertion":[{"value":"12 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}},{"value":"Vilnius regional biomedical research ethics committee approval (no. 158200-17-966- 477) was obtained before this study was conducted. The study was conducted according to the Declaration of Helsinki, and all participants gave written informed consent prior to enrolment. The study was registered at the ClinicalTrials.gov database before the start of recruitment (NCT03418428).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Informed consent was obtained from all patients.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}}]}}